NCT05736224View on ClinicalTrials.gov

Assessing a Natural Product Plus Bioadhesive Nanoparticle (BNP) Sunscreen

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 15, 2023

Primary Completion Date

September 1, 2023

Study Completion Date

September 1, 2023

Conditions
Skin Cancer
Interventions
DRUG

Sunscreen

The sunscreen contains bioadhesive nanoparticles (BNP) encapsulating avobenzone and octocrylene plus the non-toxic natural products diosmin, ferulic acid, cytisine and trans-resveratrol.

OTHER

UV Light

UV light to the correct sites, and the Multiport 610 solar simulator used to deliver 1 MED UVR to the appropriate subsites.

Trial Locations (1)

06511

Yale School of Medicine, New Haven

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Yale University

OTHER

NCT05736224 - Assessing a Natural Product Plus Bioadhesive Nanoparticle (BNP) Sunscreen | Biotech Hunter | Biotech Hunter